These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14689103)

  • 21. Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients.
    Fortunati N; Manti R; Birocco N; Pugliese M; Brignardello E; Ciuffreda L; Catalano MG; Aragno M; Boccuzzi G
    Oncol Rep; 2007 Dec; 18(6):1521-7. PubMed ID: 17982639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Responses in extracellular and intracellular calcium and magnesium in aldosteronism.
    Runyan AL; Sun Y; Bhattacharya SK; Ahokas RA; Chhokar VS; Gerling IC; Weber KT
    J Lab Clin Med; 2005 Aug; 146(2):76-84. PubMed ID: 16099237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of aldosterone receptor blocker therapy on cardiac remodeling].
    Boccanelli A; Battagliese A
    G Ital Nefrol; 2006; 23 Suppl 34():S57-63. PubMed ID: 16633997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Endocrinology of aldosterone].
    Ronconi V; Giacchetti G; Boscaro M
    Ital Heart J; 2005 May; 6 Suppl 1():5S-15S. PubMed ID: 15945295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications.
    Cooper ME
    Am J Hypertens; 2004 Nov; 17(11 Pt 2):16S-20S; quiz A2-4. PubMed ID: 15539106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic inflammation after trauma.
    Lenz A; Franklin GA; Cheadle WG
    Injury; 2007 Dec; 38(12):1336-45. PubMed ID: 18048040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
    White M; Ducharme A; Ibrahim R; Whittom L; Lavoie J; Guertin MC; Racine N; He Y; Yao G; Rouleau JL; Schiffrin EL; Touyz RM
    Clin Sci (Lond); 2006 Apr; 110(4):483-9. PubMed ID: 16402915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
    Duprez DA
    J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Activation of the renin-angiotensin-aldosterone system in heart failure].
    Volpe M; Tocci G; Pagannone E
    Ital Heart J; 2005 May; 6 Suppl 1():16S-23S. PubMed ID: 15945296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Causal link between oxidative stress, inflammation, and hypertension.
    Vaziri ND
    Iran J Kidney Dis; 2008 Jan; 2(1):1-10. PubMed ID: 19367002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune activation in chronic heart failure.
    Torre-Amione G
    Am J Cardiol; 2005 Jun; 95(11A):3C-8C; discussion 38C-40C. PubMed ID: 15925558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arterial stiffness and the renin-angiotensin-aldosterone system.
    Mahmud A; Feely J
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):102-8. PubMed ID: 15526244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of high- versus low-tissue affinity ACE-inhibitor treatment on circulating aldosterone levels in patients with chronic heart failure.
    Vittorio TJ; Ahuja K; Kasper M; Turalic H; Tseng CH; Jorde UP; Go C
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):200-4. PubMed ID: 18205099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
    Castro-Chaves P; Leite-Moreira AF
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
    Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
    Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aldosterone as a modulator of immunity: implications in the organ damage.
    Herrada AA; Campino C; Amador CA; Michea LF; Fardella CE; Kalergis AM
    J Hypertens; 2011 Sep; 29(9):1684-92. PubMed ID: 21826023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congestive heart failure: pathophysiologic consequences of neurohormonal activation and the potential for recovery: part I.
    Dube P; Weber KT
    Am J Med Sci; 2011 Nov; 342(5):348-51. PubMed ID: 22030844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.